Bleeding from endometrial and vaginal malignant tumors treated with activated recombinant factor VII.
Eur J Gynaecol Oncol 2002;23(4):325-326.
NATA Rating :
Review by :
This is a case report of two female patients with severe vaginal bleeding following previous treatment of gynecological malignancies and no pre-existing coagulation factor deficiency. Bleeding was controlled with two and one relatively small doses of rFVIIa, respectively.
– M. Aldouri